IRIS
BILO', Maria Beatrice
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.730
EU - Europa 2.101
AS - Asia 1.288
SA - Sud America 138
AF - Africa 38
OC - Oceania 4
Totale 11.299
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.711
SG - Singapore 566
HK - Hong Kong 476
RU - Federazione Russa 469
IE - Irlanda 419
IT - Italia 276
SE - Svezia 241
UA - Ucraina 207
DE - Germania 181
CN - Cina 151
BR - Brasile 123
GB - Regno Unito 97
FR - Francia 91
IN - India 52
CI - Costa d'Avorio 25
FI - Finlandia 21
AT - Austria 20
BE - Belgio 19
NL - Olanda 17
MX - Messico 9
PL - Polonia 9
ES - Italia 8
CA - Canada 7
JP - Giappone 5
KR - Corea 5
VN - Vietnam 5
ZA - Sudafrica 5
AR - Argentina 4
AU - Australia 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
IQ - Iraq 4
MA - Marocco 4
PY - Paraguay 4
LT - Lituania 3
PK - Pakistan 3
RS - Serbia 3
TR - Turchia 3
TW - Taiwan 3
VE - Venezuela 3
BD - Bangladesh 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
PE - Perù 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
GY - Guiana 1
IR - Iran 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
Totale 11.299
Salva come PNG Salva come JPEG
Città #
Des Moines 1.770
Chandler 1.018
Fairfield 535
Hong Kong 470
Jacksonville 455
Ashburn 438
Dublin 417
Houston 325
Singapore 286
Boardman 277
Woodbridge 248
Wilmington 245
Cambridge 216
Seattle 214
Lawrence 163
Princeton 163
San Mateo 142
Ann Arbor 123
Moscow 90
Redmond 87
The Dalles 86
San Diego 65
New York 60
Washington 60
Pune 49
Los Angeles 43
London 26
Abidjan 25
Dallas 24
Beijing 20
Centro 19
Nuremberg 18
Rome 18
Brussels 16
Ancona 15
Guangzhou 15
Helsinki 14
Falls Church 13
Kilburn 13
Norwalk 13
Cedar Knolls 12
Milan 11
Shenzhen 10
Manchester 9
Shanghai 9
Wuhan 8
Gatchina 7
Mexico City 7
St Petersburg 7
São Paulo 7
Vienna 7
Amsterdam 6
Charlotte 6
New Bedfont 6
Prescot 6
Squinzano 6
Stockholm 6
Turin 6
Hounslow 5
Phoenix 5
San Francisco 5
Santa Clara 5
Turku 5
West Jordan 5
Hangzhou 4
Jinhua 4
Marano Vicentino 4
Perm 4
Pescara 4
Porto Alegre 4
Redwood City 4
San Severino Marche 4
Wandsworth 4
Asunción 3
Baghdad 3
Bialystok 3
Bologna 3
Brasília 3
Civitanova Marche 3
Diano Castello 3
Duque de Caxias 3
Goiânia 3
Islington 3
Istia D'ombrone 3
Rostov-on-Don 3
San Gregorio da Sassola 3
Vallefoglia 3
Yiwu 3
Aversa 2
Barbacena 2
Belo Horizonte 2
Campinas 2
Cape Town 2
Carmignano 2
Central 2
Edinburgh 2
Fayetteville 2
Genoa 2
Hanoi 2
Heze 2
Totale 8.565
Salva come PNG Salva come JPEG
Nome #
Anaphylaxis in Elderly Patients-Data From the European Anaphylaxis Registry 217
The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paper 207
Idiopathic anaphylaxis 187
Diagnosing, managing and preventing anaphylaxis: Systematic review 142
Rhinopharyngoscopy, computed tomography and magnetic resonance imaging 139
Safety and Adherence to Venom Immunotherapy During COVID-19 Pandemic 119
Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19 116
Sensitization to Cat: Why Not Use Molecular Diagnostics instead of the Nasal Challenge in Clinical Practice? 109
Basal Tryptase High Levels Associated with a History of Arterial Hypertension and Hypercholesterolemia Represent Risk Factors for Severe Anaphylaxis in Hymenoptera Venom-Allergic Subjects over 50 Years Old 108
Diagnosis of Immediate-Type ß-Lactam Allergy In Vitro by Flow-Cytometric Basophil Activation Test and Sulfi doleukotriene Production: a Multicenter Study. 101
In vivo diagnosis of allergic diseases - allergen provocation tests 101
Unmet needs and relationship between general practitioners (GPs) and allergists living in Campania region (southern Italy) 101
Why are allergens not detected in the bronchoalveolar lavage fluid of patients undergoing fiberoptic bronchoscopy? Possible explanations 101
Forced oscillation technique as method to document and monitor the efficacy of mepolizumab in treating severe eosinophilic asthma 100
Anaphylaxis 99
Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry 98
Severe asthma in adults does not significantly affect the outcome of COVID-19 disease: Results from the Italian Severe Asthma Registry 97
Prevention and treatment of hymenoptera venom allergy: Guidelines for clinical practice 92
Oxytocin: a likely underestimated risk for anaphylactic reactions in delivering women sensitized to latex 91
Clinical aspects of hymenoptera venom allergy and venom immunotherapy 90
World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis 90
Phenotype and risk factors of venom-induced anaphylaxis: a case-control study of the European Anaphylaxis Registry 90
European hornet (Vespa crabro) sting: a new risk factor for life-threatening reaction in hymenoptera allergic patients? 89
Fatal anaphylaxis in Italy: Analysis of cause-of-death national data, 2004-2016 88
Development of a model care pathway for the management of Hymenoptera venom allergy: Evidence-based key interventions and indicators 87
Editorial: Anaphylaxis – A Distinct Immunological Syndrome, but How Much Do We Really Understand? 87
Immunotherapy for hymenoptera venom allergy: too expensive for European health care? 87
Large local reactions to Hymenoptera stings: outcome of re-stings in real-life 86
Anaphylaxis to baobab fruit: The paradox of “natural healthy food” 86
Is diet partly responsible for differences in COVID-19 death rates between and within countries? 86
Precision Medicine in Hymenoptera Venom Allergy: Diagnostics, Biomarkers, and Therapy of Different Endotypes and Phenotypes 86
Contraindications to immunotherapy: A global approach 85
Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment 85
World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settings 84
Bonifazi F. Epidemiology of Hymenoptera sting anaphylaxis 83
Detection of Gibberellin-Regulated Protein (Peamaclein) Sensitization among Italian Cypress Pollen-Sensitized Patients 83
EAACI anaphylaxis guidelines: Systematic review protocol 81
Diagnosis of Hymenoptera venom allergy 81
Allergen immunotherapy for insect venom allergy: protocol for a systematic review 80
The role of component-resolved diagnosis in Hymenoptera venom allergy 80
Shortness of interval between two stings as risk factor for developing Hymenoptera venom allergy 80
The natural history and epidemiology of insect venom allergy: clinical implications 80
Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper 80
Advances in Hymenoptera venom immunotherapy 80
Shedding Light on the Venom Proteomes of the Allergy-Relevant Hymenoptera Polistes dominula (European Paper Wasp) and Vespula spp. (Yellow Jacket) 79
Anisakis hypersensitivity in Italy: prevalence and clinical features: a multicenter study. 79
International consensus on (ICON) anaphylaxis 79
Risk Factors and Characteristics of Biphasic Anaphylaxis 78
Anaphylaxis in children and adolescents: The European Anaphylaxis Registry 77
Mast cell diseases and the severity and course of intraoperative anaphylaxis 77
Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase 77
Insect sting anoxic encephalopathy after stopping venom immunotherapy. 77
Congruence between international guidelines and mite specific immunotherapy prescribing practices 76
Antigen 5 Allergens of Hymenoptera Venoms and Their Role in Diagnosis and Therapy of Venom Allergy 76
Epidemiology of hymenoptera allergy 76
Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergy 75
Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy 75
The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extracts 74
World Allergy Organization anaphylaxis guidelines: Summary 73
Efficacy of an air‐cleaning device equipped with a high efficiency particulate air filter in house dust mite respiratory allergy 73
Clinical effectiveness of hymenoptera venom immunotherapy: a prospective observational multicenter study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivity 72
Hyposensitization therapy of Parietaria-sensitive patients with a tyrosine adsorbed allergoid, Pollinex Parietaria (Bencard Parietaria) 71
Lysozyme, a new allergen in donkey's milk 70
Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected 70
Hymenoptera Venom Allergy: Management of children and adults in clinical practice 70
High long-term efficacy of venom immunotherapy after discontinuation 70
Hymenoptera Venom Allergy - European Academy of Allergy and Clinical Immunology Monographs 70
Treating venom allergy during COVID-19 pandemic 70
Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis 69
Epinephrine in Severe Allergic Reactions: The European Anaphylaxis Register 69
Anxiety and depression in adolescents with asthma and in their parents. Is an increased basal cholinergic tone a possible further reason to explain the negative impact on asthma control? 69
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian multicenter study 69
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy 69
Honeybee venom immunotherapy: a comparative study using purified and nonpurified aqueous extracts in patients with normal Basal serum tryptase concentrations 69
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper 68
CAP-Inhibition, Molecular Diagnostics, and Total IgE in the Evaluation of Polistes and Vespula Double Sensitization 68
Omalizumab in chronic spontaneous urticaria: patient-tailored tapering or planned discontinuation? 68
Anxiety/depression and impaired asthma control in adolescents. Is an increased basal cholinergic tone a possible link ? 68
First European data from the network of severe allergic reactions (NORA) 68
Hymenoptera Venom Immunotherapy: How to Safely Switch to the Same Venom From a Different Manufacturer 67
Safety of a 2-day ultrarush immunotherapy in vespid allergic patients: Focus on elevated serum tryptase 67
Ves v 5 can establish the diagnosis in patients without detectable specific IgE to wasp venom and a possible north-south difference in Api m 1 sensitization in Europe 67
Purified vs. nonpurified venom immunotherapy 67
Use of adrenaline in allergy 67
High adherence to hymenoptera venom subcutaneous immunotherapy over a 5-year follow-up: A real-life experience 66
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 65
European Polistes venom allergy 65
Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity 65
Oxytocin: an unexpected risk for cardiologic and broncho-obstructive effects, and allergic reactions in susceptible delivering women 65
Component resolved diagnosis in real life: the risk assessment of food allergy using microarray-based immunoassay 65
Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice 65
Efficacy of a single dose of omalizumab for the prevention of ethylene oxide intraoperative anaphylaxis 64
Intraoperative anaphylaxis: verba volant, scripta manent! 64
Vespid allergy 63
Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy Reply 63
Diagnosis of immediate-type beta-lactam allergy in vitro by flow-cytometric basophil activation test and sulfidoleukotriene production: a multicenter study 63
Honeybee venom immunotherapy: certainties and pitfalls 62
2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis 62
Risk of severe anaphylaxis for patients with Hymenoptera venom allergy: Are angiotensin-receptor blockers comparable to angiotensin-converting enzyme inhibitors? Reply 61
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies 60
Totale 8.330
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.040
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020290 0 0 0 0 0 0 0 0 0 0 122 168
2020/20212.127 116 179 260 87 430 113 114 180 191 143 221 93
2021/20221.200 61 235 18 35 21 69 46 94 106 75 132 308
2022/20234.055 228 212 169 261 177 1.998 1 167 588 23 166 65
2023/20241.392 268 39 119 139 223 271 23 46 7 53 19 185
2024/20252.189 100 232 100 74 63 174 207 94 809 210 126 0
Totale 11.592